Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIELD I: D-PLEX in Prevention of Post Abdominal Surgery Incisional Infection
NCT04233424Phase 3Completed
- Sponsor
- PolyPid Ltd.
- Start
- Jun 2020
- Primary completion
- Sep 2022
- Modality
- Polymer-based Nanoparticles, Device-based Delivery, Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of D-PLEX100 in surgical site infection (SSI), sponsored by PolyPid Ltd.. Started Jun 2020; status: completed.
02
Drugs
D-PLEX100
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04233424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04233424.